Abbott Laboratories Reports Earnings Results for the Fourth Quarter Ended December 31, 2018
January 23, 2019 at 07:45 am EST
Abbott Laboratories announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 7,765 million compared to USD 7,589 million a year ago. Operating income was USD 1,165 million compared to USD 651 million a year ago. Net income was USD 654 million compared to net loss of USD 828 million a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to diluted loss per share from continuing operations of USD 0.5 a year ago. Diluted earnings per share was USD 0.37 compared to diluted loss per share of USD 0.48 a year ago. For the full year, sales was USD 30,578 million compared to USD 27,390 million a year ago. Operating income was USD 3,650 million compared to USD 1,564 million a year ago. Net income was USD 2,368 million compared to USD 477 million a year ago. Diluted earnings per share from continuing operations was USD 1.31 compared to USD 0.2 a year ago. Diluted earnings per share was USD 1.33 compared to USD 0.27 a year ago.